One of the challenges facing the US healthcare system is the ability to comprehensively
serve those with relatively rare and complex disorders, particularly for those conditions that …

Sickle cell disease (SCD) is a collection of inherited blood disorders that affect a substantial
number of people in the US, particularly African Americans. People with SCD have an …

The US has made enormous progress in the care of people with sickle cell disease (SCD)
over the past 4 decades. Even in the absence of the discovery of new medications, median …

Sickle cell disease (SCD) is a genetic condition that affects approximately 100,000 people in
the United States and millions more globally. Individuals with SCD endure the psychological …

Context: Sickle cell disease is a group of conditions characterized by production of abnormal
hemoglobin, with clinical manifestations that vary by genotype and age. Objective: To …

Research into sickle cell disease (SCD), which disproportionately affects historically
underserved ethnic and racial groups, lacks funding and resources. The Centers for Disease …

Background Improved health care for children with sickle cell disease has increased the
likelihood of survival to young adulthood for those born in the US with this inherited rare …

Sickle cell disease (SCD) is the most common hemoglobinopathy in the United States and
causes significant disease-related morbidity including multiorgan damage, chronic anemia …

Purpose: To familiarize primary care providers (PCPs) with the pathophysiological
processes, diagnostic evaluation, and medical management of sickle hemoglobinopathies …

With increasing burdens placed on Primary Care Physicians in the prevention and
management of Sickle Cell Disease (SCD), it is imperative that there is some basic …